388 related articles for article (PubMed ID: 12486618)
21. [Studies of the clinical and respiratory functional effects of a mucolytic-antibiotic preparation in chronic bronchopulmonary diseases. Controlled double-blind single code studies].
Alberto S; Colongo PG; Brusasco L; Frigerio G
Minerva Med; 1968 Jul; 59(53):2995-3002. PubMed ID: 5671380
[No Abstract] [Full Text] [Related]
22. [Acetylcysteine in bronchitis and pneumonia].
Vogelmeier C
Internist (Berl); 1999 Oct; 40(10):1102-3. PubMed ID: 10610368
[No Abstract] [Full Text] [Related]
23. [Clinicomicrobiological monitoring of patients with exacerbation of chronic bronchitis treated with antibacterial drugs].
Dvoretskiĭ LI; Dubrovskaia NV; Grudinina SA; Filimonova OIu; Iakovlev SV; Sergeeva EV; Sidorenko SV
Ter Arkh; 2006; 78(3):25-35. PubMed ID: 17019954
[TBL] [Abstract][Full Text] [Related]
24. [Comparative studies on the mucolytic effectiveness of Mucosolvin oral and Mucosolvin inhalant].
Fischer JF; Scheuler D
Z Erkr Atmungsorgane; 1986; 167(1-2):96-102. PubMed ID: 3765720
[TBL] [Abstract][Full Text] [Related]
25. Oxidation pathway and exacerbations in COPD: the role of NAC.
Matera MG; Calzetta L; Cazzola M
Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
[TBL] [Abstract][Full Text] [Related]
26. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM
Thorax; 2008 May; 63(5):415-22. PubMed ID: 18234905
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.
Aylward M; Maddock J; Dewland P
Eur J Respir Dis Suppl; 1980; 111():81-9. PubMed ID: 7011835
[No Abstract] [Full Text] [Related]
28. Mucolytic agents.
Br Med J; 1971 Jun; 2(5761):581-2. PubMed ID: 5579199
[No Abstract] [Full Text] [Related]
29. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?
Riise GC; Larsson S; Larsson P; Jeansson S; Andersson BA
Eur Respir J; 1994 Jan; 7(1):94-101. PubMed ID: 8143838
[TBL] [Abstract][Full Text] [Related]
30. [Therapy of bronchitis in childhood with Eprazinone (author's transl)].
Rudkowski Z; Latos T
Padiatr Padol; 1980; 15(4):351-64. PubMed ID: 7007990
[TBL] [Abstract][Full Text] [Related]
31. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
33. [On the treatment of chronic bronchitis, a therapeutic study].
Renovanz HD; Liebrich KG
Arzneimittelforschung; 1967 Jan; 17(1):37-46. PubMed ID: 5632525
[No Abstract] [Full Text] [Related]
34. [Antibacterial therapy of acute exacerbated chronic bronchitis].
Forche G
Wien Med Wochenschr; 1986 Dec; 136(23-24):633-7. PubMed ID: 3105183
[TBL] [Abstract][Full Text] [Related]
35. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
36. [Acute bronchitis: when are antibiotics, and when is symptomatic treatment indicated?].
Gillissen A; Gessner C; Hammerschmidt S; Hoheisel G; Wirtz H
MMW Fortschr Med; 2006 Jan; 148(1-2):26-8. PubMed ID: 16610409
[TBL] [Abstract][Full Text] [Related]
37. N-acetylcysteine in patients with COPD exacerbations associated with increased sputum.
Ayfer Aytemur Z; Baysak A; Ozdemir O; Köse T; Sayiner A
Wien Klin Wochenschr; 2015 Apr; 127(7-8):256-61. PubMed ID: 25595117
[TBL] [Abstract][Full Text] [Related]
38. Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study.
Eur J Respir Dis Suppl; 1980; 111():93-108. PubMed ID: 7011836
[No Abstract] [Full Text] [Related]
39. The role of antibiotics in the management of acute exacerbation of chronic bronchitis (answers to some commonly asked questions).
Skudlarska BA; Scott GC
Mo Med; 1992 May; 89(5):289-93. PubMed ID: 1608387
[TBL] [Abstract][Full Text] [Related]
40. The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study.
de Gussem EM; Snijder RJ; Disch FJ; Zanen P; Westermann CJ; Mager JJ
Rhinology; 2009 Mar; 47(1):85-8. PubMed ID: 19382502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
